COVID: Moderna Says New Vaccine Protects Against Omicron

    Photo: The New York Times

    The Facts

    • In a release on Wed., Moderna announced that data has shown a new version of its COVID vaccine to be more effective in protecting against the virus.

    • Their studies reportedly show that the new dose offers recipients better chances of producing antibodies against Omicron. Dr Stephen Hodge, president of Moderna, has said that the company believes the findings support the implementation of the new vaccine.

    The Spin

    Narrative A

    With concerns over waning vaccine immunity and the potential for a surge in cases in the fall, these results should be celebrated. Though some are worried about what role COVID will have in our daily lives when summer draws to a close, a highly effective bivalent vaccine could be the first step on the roadmap to annual COVID treatments and a return to normality.

    Establishment-critical narrative

    Whilst Moderna deserves credit for developing and rolling out an effective COVID vaccine with astounding speed, they are now profiteering from the virus. The pharmaceutical giant made $7.3B in after-tax profits in the first three quarters of 2021, now it is seeking further authorization to continue global sales.

    Nerd narrative

    There is a 50% chance that at least 95.3k people will be reported to have died per year from COVID-19 on average between 2022-2025 in the US, according to the Metaculus prediction community

    Establishment split



    More neutral establishment stance articles

    Sign up to our daily newsletter